Dr. Ginde, PI of the ATLAS Research Program, is Senior Associate Dean for Clinical Research, Assistant Vice Chancellor for Clinical Trials, and Professor of Emergency Medicine and Anesthesiology at CU Anschutz. His research focuses on epidemiological and clinical trials in the acute care setting, with a particular focus on early interventions for critically ill and injured patients, in a variety of clinical environments including emergency department, intensive care unit, and other inpatient units, perioperative, and outpatient settings.

Dr. Ginde has been the lead investigator for 14 large multicenter clinical trials and participated in the design (as protocol committee member and co-investigator) and implementation (as site PI) of over 25 other clinical trials. National leadership in clinical trials networks include the NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) network executive and steering committees and steering committees for the NHLBI Collaborating Network of Networks for Evaluating COVID-19 and Therapeutic Strategies (CONNECTS), the trans-NIH Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-3, the NIAID Strategies and Treatments for Respiratory & Viral Diseases (STRIVE), the CDC-funded Influenza and Other Viruses in the Acutely Ill (IVY), the DoD- and PCORI-funded Pragmatic Critical Care Research Group (PCCRG), DoD-funded SAVE-O2, and DoD-funded RESOLUTE networks.

He has published over 400 original research articles in leading medical journals, including regular contributions to NEJM, JAMA, and Lancet journals. 

Dr. Bills, co-PI of the ATLAS Research Program, is an Associate Professor of Emergency Medicine at the CU Anschutz School of Medicine, Senior Investigator in the Colorado School of Public Health, Center for Global Health and Affiliate Faculty of the University of Colorado Combat Medicine Research Center.

He serves as the Director of the University of Colorado WHO Collaborating Centre for Acute Care, the Global Emergency Medicine Initiative and the Fellowship Program in Global Emergency Care and Public Health—a two year post graduate research and training fellowship for emergency trained physicians interested in global health. He has a 20-year career in global health research, having received federal and international funding and consulted with multiple universities, governments, and non-governmental organizations on implementation science research.

He has particular expertise in research on emergency care health systems strengthening, acute and trauma care program implementation, monitoring and evaluation, epidemiologic and implementation science methods, and international clinical trials.

Dr. David "Josh" Douin, co-PI of the ATLAS Research Program, is an Associate Professor in the Department of Anesthesiology at CU Anschutz School of Medicine. He earned his medical degree from Tufts University School of Medicine, followed by residency training in anesthesiology and a fellowship in critical care medicine at the University of Colorado. He currently attends in the Surgical Trauma Intensive Care Unit (STICU) and operating rooms at UCHealth.  

Dr. Douin's research focuses on epidemiological and clinical trials involving critically ill patients, with particular emphasis on oxygen delivery, blood transfusion strategies, and trauma care. He served as co-principal investigator for the multicenter SAVE-O2 trials that assessed the effects of a targeted normoxemia strategy for critically ill trauma and burn patients. He was also the co-PI for the multicenter SAVE-O2 AI trial investigating autonomous oxygen titration for acutely ill patients.  

Currently, Dr. Douin is the scientific lead and co-PI for the multicenter EFFECT clinical trial assessing the role of early fibrinogen replacement for critically ill trauma patients with major hemorrhage. His work is supported by funding from the NIH, the Department of Defense, and Octapharma.

Erin Anderson serves as Manager of the ATLAS Research Program in the Department of Emergency Medicine at CU Anschutz. She provides strategic and operational leadership for the program and oversees a diverse portfolio of NIH, Department of Defense, and industry-sponsored studies. Her work focuses on fostering collaborative research teams, strengthening research infrastructure, and translating clinical research findings into practice to advance patient care and improve health outcomes. 

Erin joined Dr. Ginde’s research program in 2017 following three years as a clinical trials nurse and a five-year career as a cardiac step-down nurse. Since joining the program, she has led and supported numerous interventional and observational studies focused on sepsis, airway management, COVID-19 therapeutics and surveillance, oxygenation strategies, and wound infections; with specific attention to clinical coordination and operations of multisite clinical trials. She has also led strategic development and process improvement initiatives designed to enhance the efficiency and effectiveness of the ATLAS research program. 

In her current role, Erin oversees research strategy, study operations, budget and contract management, budget negotiations, regulatory compliance, subaward and vendor management, stakeholder engagement, and the development of efficient research infrastructure and processes. She leads a multidisciplinary team of 18 research and business professionals and supports 12 principal investigators in the successful execution of their research programs. 

Jennifer Peers, MPH, RN, serves as Manager for the ATLAS Research Program in the Department of Emergency Medicine at the University of Colorado Anschutz Medical Campus. In this role, she helps oversee clinical research operations across a diverse portfolio of federally and industry-funded studies, helping advance innovative research that improves outcomes for critically ill and injured patients. 

With a former 10-year career as an Emergency Department and Critical Care nurse, she joined Dr. Ginde and the ATLAS Research Lab in 2019. Since then, she has led and supported numerous interventional and observational trials focused on vaccine effectiveness, oxygenation strategies, COVID-19, sepsis, trauma, cardiac arrest, traumatic brain injury, and wound infections. She earned her Master of Public Health in Global Health Epidemiology from the University of Colorado in 2025. 

Currently, Jennifer helps oversee the day-to-day operations of the ATLAS research lab and co-manages a team of 13 research professionals. Her responsibilities include operational oversight, staff leadership, regulatory compliance, and stakeholder engagement and collaboration. She also serves as the local project lead for the Antimicrobial Resistance Research to Improve Outcomes of Traumatic Wounds (ARROW) study, part of the RESOLUTE platform, which is an international initiative aimed at improving care on the front lines in Ukraine.  

Amanda Martinez, MPH, serves as Manager of the ATLAS Research Program. She assists with and oversees the day-to-day operations of clinical trials, co-manages the responsibilities of a team of 13 research professionals, and fosters collaborations between research and clinical professionals and key stakeholders. Since joining Dr. Adit Ginde, MD, MPH, and the ATLAS Research Program in 2020 as a Research Service Professional, she has led and contributed to numerous COVID-19 interventional research trials, a vaccine effectiveness surveillance program for respiratory illnesses, an observational sepsis trial, and supported multiple other projects pertaining to trauma, major burn, oxygenation, lung injury prevention, cardiac arrest, and traumatic brain injury. 

Amanda is the regulatory lead for the Clinical Coordinating Center of a multicenter randomized clinical trial comparing fibrinogen concentrate versus cryoprecipitate-based structured usual care among adult trauma patients with major hemorrhage and acquired fibrinogen deficiency (EFFECT), the local project lead for the biomedical emergency, acute, and critical care trials and observational network (BEACON), and the regulatory project manager for the United States precision medicine adaptive network platform trial in hypoxemic acute respiratory failure (US PANTHER). 

Amanda earned her Master’s degree in Public Health from Washington University in St. Louis in 2018, and began her research career as a data manager for Phase I Hematology and Oncology clinical trials at the University of Miami Health System. 

Laurel is a Senior Research Scientist and biostatistician at the Center for Innovative Design and Analysis (CIDA) at CU Anschutz and the Lead Biostatistician for the ATLAS Research Group. Her work focuses on clinical trials, real-world evidence, and collaborative biomedical research. She provides statistical and scientific leadership across large, multidisciplinary research teams, with experience spanning study design, grant development, statistical analysis, and dissemination.

Laurel is also passionate about building strong research teams and developing collaborative systems that help people work effectively and produce rigorous, impactful science.